# Reliance Life Sciences Private Limited - Inspection Records

Source: https://www.keypedia.com/companies/reliance-life-sciences-private-limited/14b16d70-e482-4647-a231-4eb4a1aab98f

> Inspection records and compliance data for Reliance Life Sciences Private Limited in Navi Mumbai, None. Access full analysis and detailed observations.

---

## Details

- Name: Reliance Life Sciences Private Limited
- FEI Number: 3009510975
- City: Navi Mumbai
- State: None
- Country Name: India
- Address Line 1: Ttc Area Of Midc, R - 282 Dhirubhai Ambani Life Sciences Centre; Thane Belapur Road
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK

## Related Documents

- [WARNING_LETTER - Reliance Life Sciences Private Limited - 2026-02-27](https://www.keypedia.com/records/warning_letter/reliance-life-sciences-private-limited/ba7fe25d-ffe5-4555-a2f6-20bff3df6625) — source: FDA, date: February 27, 2026
- [483 - Reliance Life Sciences Private Limited - 2026-02-27](https://www.keypedia.com/records/483/reliance-life-sciences-private-limited/43ee35e0-0c20-4849-9f73-a6f046f78841) — source: FDA, date: February 27, 2026
- [483 - Reliance Life Sciences Private Limited - 2026-02-27](https://www.keypedia.com/records/483/reliance-life-sciences-private-limited/47dfda7e-50c5-402d-8722-6d7100a1f1e7) — source: FDA, date: February 27, 2026
- [FDA Inspection 1311632 - Reliance Life Sciences Private Limited - 2026-02-27](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/ccab4917-175f-46db-ad0c-ba158ab3159d) — source: FDA, date: February 27, 2026
- [FDA Inspection 1170339 - Reliance Life Sciences Private Limited - 2022-04-15](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/25bd4384-4ea7-4998-8065-2fb38edb15d1) — classification: No Action Indicated (NAI), source: FDA, date: April 15, 2022
- [FDA Inspection 1113122 - Reliance Life Sciences Private Limited - 2019-11-22](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/b6113606-88ad-4489-b518-74dc92f5f967) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2019
- [FDA Inspection 1070144 - Reliance Life Sciences Private Limited - 2018-10-16](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/f81e0521-c3a6-4bcf-9fb0-651407a13902) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2018
- [FDA Inspection 1047623 - Reliance Life Sciences Private Limited - 2018-01-25](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/97b25c8c-27f6-433b-b21d-d196bf1897c6) — classification: No Action Indicated (NAI), source: FDA, date: January 25, 2018
- [FDA Inspection 1035956 - Reliance Life Sciences Private Limited - 2017-12-13](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/568afd53-47df-4520-baef-a07fc7d6165e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2017
- [FDA Inspection 940150 - Reliance Life Sciences Private Limited - 2015-08-14](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/31fccf0e-5d28-486d-93c4-e941ab976fbf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 14, 2015
- [FDA Inspection 847082 - Reliance Life Sciences Private Limited - 2013-08-23](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/49d09572-c747-4753-a295-f4c2867c30f1) — classification: Official Action Indicated (OAI), source: FDA, date: August 23, 2013

## Related Companies

- [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/9d02bb1e-32f9-45c5-9b90-f52622553c63)
- [Changzhou Pharmaceutical Factory](https://www.keypedia.com/companies/changzhou-pharmaceutical-factory/eea165e1-3df2-47c8-94b9-e8400af46bc4)
- [Merck Sharp & Dohme LLC](https://www.keypedia.com/companies/merck-sharp-dohme-llc/842c6e25-ee89-453c-a5b0-6b039c187744)
- [Qilu Antibiotics Pharmaceutical Co. , Ltd.](https://www.keypedia.com/companies/qilu-antibiotics-pharmaceutical-co-ltd/f1c696c7-317f-4fb9-92a1-df8381af004c)
- [Ferring Microbiome Inc.](https://www.keypedia.com/companies/ferring-microbiome-inc/860d4130-d93a-4017-97ca-30033280de85)
- [Latina Pharma S.p.A.](https://www.keypedia.com/companies/latina-pharma-spa/9cb7e758-39a0-4b4c-bfad-93d1468f5d38)
- [Amgen, Inc.](https://www.keypedia.com/companies/amgen-inc/85ec512e-6991-42ee-9cd5-148cfe0ed3e8)
- [Vericel Corporation](https://www.keypedia.com/companies/vericel-corporation/1955c523-5115-491b-a705-2c526deb9ff6)
- [Anhui Poly Pharm. Co., Ltd.](https://www.keypedia.com/companies/anhui-poly-pharm-co-ltd/e1d9c61f-37b4-4759-8c00-51c6d0b78d3b)
- [Aprecia Pharmaceuticals LLC](https://www.keypedia.com/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3)

## Related Officers

- [Eileen A. Liu](https://www.keypedia.com/people/eileen-a-liu/fa051db4-1242-4181-9af9-5b3cd2de5689)
- [Ashar P. Parikh](https://www.keypedia.com/people/ashar-p-parikh/f5430c51-31c7-44bb-90f7-1ec8ae581343)
- [Director](https://www.keypedia.com/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)